Serum Vascular Endothelial Growth Factor Level in Patients with Hematological Malignancies

leukemia, chronic leukemia, myelodysplastic syndromes, lymphomas and multiple myeloma. (6,13-19). Although increased angiogenesis in solid hematological

More PDF Content

SERUM VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES, Aim, Methods, Results, Conclusion, Key words, Eur J Gen Med 2006; 3(3):116-120, INTRODUCTION, Correspondence, 1. Comparison of VEGF levels, between study and control groups, MATERIAL AND METHODS, RESULTS, Table 1. Comparison of serum VEGF levels of hematological malignancy subgroups and, control group. 2. Comparison of serum VEGF levels, of hematological malignancy subgroups, and control group, DISCUSSION, REFERENCES

Download Serum Vascular Endothelial Growth Factor Level in Patients with Hematological Malignancies pdf from www.ejgm.org, 5 pages, 317.03KB.